GO:0004352 L-glutamate dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004352 describes the molecular function of L-glutamate dehydrogenase (NAD+) activity, which catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate using NAD+ as the electron acceptor.
• This activity is central to mitochondrial glutamate metabolism and links amino acid catabolism to the TCA cycle and cellular redox balance.
• GLUD1 is the primary mammalian gene encoding NAD-dependent glutamate dehydrogenase, and its loss or dysregulation affects stem cell fate and mitochondrial function.
• NAD-GDH enzymes are found across all domains of life, from bacteria and archaea to plants and animals, with diverse regulatory properties.
• Enzyme activity is modulated by allosteric effectors such as L-leucine and TCA cycle intermediates, which fine-tune flux through this metabolic node.
• Dysregulated glutamate dehydrogenase activity has been linked to oxidative stress, ischemia, and metabolic disorders, making it a target for mechanistic and therapeutic studies.
Description
L-glutamate dehydrogenase (NAD+) activity, encoded by GO:0004352, is a fundamental enzymatic function that bridges amino acid metabolism and cellular energy production. It catalyzes the reversible conversion of L-glutamate to 2-oxoglutarate and ammonia, using NAD+ as a cofactor to generate NADH. This reaction sits at the intersection of nitrogen disposal, TCA cycle anaplerosis, and redox homeostasis, making it essential for mitochondrial function in diverse organisms. Researchers study this activity to understand how cells balance glutamate levels, maintain metabolic flux, and respond to stress. In mammals, the GLUD1 gene product is a key mitochondrial enzyme whose activity influences stem cell fate and tissue regeneration. In microorganisms, NAD-dependent glutamate dehydrogenases exhibit unique structural and regulatory features that inform evolutionary and biotechnological studies. Because of its central metabolic role, GO:0004352 is a recurring annotation in genome-scale models and a target for functional genomics.
L-glutamate dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0004352 |
|---|---|
| GO term | L-glutamate dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | NAD-dependent glutamate dehydrogenase activity; glutamic dehydrogenase activity; NAD-linked glutamate dehydrogenase activity; L-glutamate:NAD+ oxidoreductase (deaminating) |
| Major function | Catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate and ammonia, using NAD+ as an electron acceptor. |
| Reaction | L-glutamate + NAD+ + H2O = 2-oxoglutarate + NH4+ + NADH + H+ |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide, oxidized form) |
| Subcellular location | Mitochondrial matrix in eukaryotes; cytoplasm in some bacteria and archaea. |
| Regulation | Allosterically activated by L-leucine and modulated by TCA intermediates and amino acids. |
What Is GO:0004352?
GO:0004352 defines the molecular function of L-glutamate dehydrogenase (NAD+) activity, which catalyzes the reaction: L-glutamate + NAD+ + H2O = 2-oxoglutarate + NH4+ + NADH + H+. This activity is strictly NAD-dependent, distinguishing it from NADP-dependent glutamate dehydrogenases. It enables the oxidative deamination of glutamate, producing 2-oxoglutarate for the TCA cycle and reducing NAD+ to NADH, thereby linking amino acid catabolism to energy metabolism and redox balance.
Why Is L-glutamate dehydrogenase (NAD+) activity Important in Cell Biology?
GO:0004352 is critically important because it governs a metabolic checkpoint that influences cellular energy status, nitrogen balance, and redox homeostasis. In mammals, the NAD-dependent glutamate dehydrogenase GLUD1 controls mitochondrial glutamate levels and thereby determines muscle stem cell fate, linking nutrient metabolism to tissue regeneration. In pathogenic and environmental microorganisms, NAD-GDH activity affects survival and metabolic flexibility. Dysregulation of this activity has been implicated in oxidative stress-related pathologies such as brain ischemia, where glutamate excitotoxicity and mitochondrial dysfunction converge. Thus, understanding GO:0004352 provides insights into fundamental metabolism and offers potential targets for metabolic and neurological disorders.
• Regulates mitochondrial glutamate levels and influences stem cell differentiation and tissue repair.
• Connects amino acid catabolism to the TCA cycle by producing 2-oxoglutarate.
• Maintains redox balance by generating NADH, which feeds into oxidative phosphorylation.
• Modulates nitrogen disposal through ammonia release, impacting cellular pH and nitrogen homeostasis.
• Is allosterically regulated by L-leucine, linking branched-chain amino acid metabolism to glutamate flux.
• Exhibits diverse regulatory properties across species, from psychrophilic bacteria to halophilic archaea.
• Plays a role in oxidative stress responses and ischemic brain injury.
• Serves as a target for metabolic engineering and drug discovery in cancer and metabolic diseases.
Molecular Mechanism of L-glutamate dehydrogenase (NAD+) activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs glutamate and NAD+ and converts them into a TCA cycle intermediate and ammonia.
L-glutamate dehydrogenase (NAD+) binds L-glutamate and NAD+ in its active site. The enzyme catalyzes the oxidative deamination of glutamate, transferring a hydride from glutamate to NAD+ to form NADH, and releasing ammonia and 2-oxoglutarate. This reaction is reversible, allowing the enzyme to also assimilate ammonia into glutamate under certain conditions. Structural studies of NAD-dependent glutamate dehydrogenases from bacteria and archaea have revealed conserved residues involved in substrate and cofactor binding.
Cofactor Specificity and Redox Coupling
In simple terms: The enzyme uses NAD+ specifically, not NADP+, to accept electrons and produce NADH.
GO:0004352 explicitly requires NAD+ as the electron acceptor. This distinguishes it from NADP-dependent glutamate dehydrogenases, which use NADP+ and typically function in biosynthesis. The production of NADH directly couples glutamate oxidation to the mitochondrial electron transport chain and cellular redox state. The NAD+ specificity is determined by the enzyme's active site architecture, as shown in characterized NAD-GDHs from Janthinobacterium lividum and Halobacterium halobium.
Allosteric Regulation by Metabolites
In simple terms: Small molecules like leucine and TCA intermediates can switch the enzyme's activity up or down.
NAD-dependent glutamate dehydrogenase activity is subject to allosteric regulation. L-leucine activates the enzyme, providing a link between branched-chain amino acid availability and glutamate metabolism. In halophilic archaea, TCA cycle intermediates and amino acids modulate NAD-GDH activity, allowing fine-tuning of metabolic flux. In the protozoan Trypanosoma cruzi, regulatory studies have shown that the enzyme responds to various metabolic effectors, reflecting its role in adaptation to different nutritional environments.
Isozymes and Structural Diversity
In simple terms: Different organisms have different versions of the enzyme, some with multiple forms.
NAD-dependent glutamate dehydrogenases exist as multiple isozymes in some organisms. In the green alga Chlamydomonas reinhardtii, three NAD(P)+ isozymes of L-glutamate dehydrogenase have been purified and characterized, each with distinct kinetic and regulatory properties. The very large NAD-dependent glutamate dehydrogenase from the psychrophile Janthinobacterium lividum exhibits unique structural features adapted to cold environments. This diversity underscores the evolutionary plasticity of GO:0004352 and its adaptation to varied physiological niches.
Role in Mitochondrial Glutamate Homeostasis
In simple terms: The enzyme helps keep glutamate levels balanced inside mitochondria, which is important for cell fate decisions.
In mammalian cells, GLUD1, the primary NAD-dependent glutamate dehydrogenase, localizes to the mitochondrial matrix where it regulates glutamate levels. Studies in murine muscle stem cells have shown that GLUD1 determines cell fate by controlling mitochondrial glutamate levels; loss of GLUD1 alters the balance between quiescence and activation. This function connects GO:0004352 to stem cell biology and tissue regeneration, highlighting its importance beyond basic metabolism.
Key Genes Involved in GO:0004352 L-glutamate dehydrogenase (NAD+) activity
The following genes encode enzymes with NAD-dependent glutamate dehydrogenase activity or are directly associated with its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLUD1 | Encodes the mitochondrial NAD-dependent glutamate dehydrogenase in mammals; regulates glutamate levels and stem cell fate. | Knockout and point mutation models to study muscle stem cell fate and mitochondrial metabolism. |
| GDH1 (Janthinobacterium lividum) | Encodes a very large NAD-dependent glutamate dehydrogenase adapted to cold. | Biochemical and structural studies of cold-adapted enzymes. |
| gdhA (Halobacterium halobium) | Encodes NAD-glutamate dehydrogenase regulated by TCA intermediates and amino acids. | Studies of halophilic enzyme regulation and stability. |
| GDH1 (Chlamydomonas reinhardtii) | One of three NAD(P)+ isozymes of L-glutamate dehydrogenase. | Comparative enzymology and isozyme-specific functions. |
| GDH (Trypanosoma cruzi) | L-glutamate dehydrogenase from epimastigotes; regulatory studies. | Drug target exploration in parasitic diseases. |
| GLUD2 | Human-specific glutamate dehydrogenase isozyme (NAD-dependent) with distinct regulatory properties. | Evolutionary and neurological studies; potential role in brain metabolism. |
| GLUD1 (mouse) | Murine ortholog of GLUD1; controls mitochondrial glutamate in muscle stem cells. | Genetic models for stem cell and metabolic research. |
| GDH (E. coli) | NAD-dependent glutamate dehydrogenase involved in nitrogen metabolism. | Microbial genetics and metabolic engineering. |
| GDH (Bacillus subtilis) | Catabolic glutamate dehydrogenase for nitrogen assimilation. | Spore formation and nitrogen regulation studies. |
| GDH (Saccharomyces cerevisiae) | NAD-dependent glutamate dehydrogenase (GDH1/GDH3) in nitrogen catabolism. | Yeast metabolic models and gene regulation. |
| GDH (Arabidopsis thaliana) | NAD-dependent glutamate dehydrogenase in plant nitrogen metabolism. | Plant physiology and stress response studies. |
| GDH (Neurospora crassa) | NAD-dependent glutamate dehydrogenase involved in nitrogen catabolism. | Fungal genetics and circadian rhythm studies. |
| GDH (Corynebacterium glutamicum) | NAD-dependent glutamate dehydrogenase for glutamate production. | Industrial amino acid fermentation. |
| GDH (Thermus thermophilus) | Thermostable NAD-dependent glutamate dehydrogenase. | Biocatalysis and structural studies. |
| GDH (Clostridium symbiosum) | NAD-dependent glutamate dehydrogenase with unique allosteric properties. | Enzyme mechanism and evolution studies. |
| GDH (Bos taurus) | Bovine NAD-dependent glutamate dehydrogenase used in classical enzymology. | Allosteric regulation and kinetics. |
| GDH (Homo sapiens GLUD1) | Human mitochondrial NAD-dependent glutamate dehydrogenase; hyperinsulinism/hyperammonemia syndrome associated. | Disease modeling and pharmacological targeting. |
How Is L-glutamate dehydrogenase (NAD+) activity Regulated?
NAD-dependent glutamate dehydrogenase activity is regulated at multiple levels. Allosteric activation by L-leucine directly stimulates enzyme activity, linking amino acid availability to glutamate flux. In halophilic archaea, TCA cycle intermediates and amino acids modulate activity, suggesting feedback regulation by metabolic status. In mammals, GLUD1 expression and activity are influenced by mitochondrial glutamate levels and cellular energy demands, as shown in muscle stem cells where GLUD1 loss alters cell fate. Additionally, oxidative stress can impact enzyme function, as seen in brain ischemia where oxidative damage may affect glutamate dehydrogenase activity. These regulatory mechanisms ensure that GO:0004352 is finely tuned to cellular metabolic needs.
L-glutamate dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLUD1 | Hyperinsulinism/hyperammonemia syndrome; metabolic dysregulation | Knockout and point mutation cell models to assess insulin secretion and ammonia handling |
| GLUD1 | Muscle stem cell fate and regeneration | Conditional knockout mouse models and primary myoblast cultures |
| GLUD1 | Brain ischemia and oxidative stress | Neuronal cell lines with GLUD1 knockout or overexpression under oxidative stress |
| GDH (Trypanosoma cruzi) | Parasitic infection | Enzyme inhibition assays and parasite knockout models |
| GDH (Halobacterium halobium) | Halophilic adaptation | Site-directed mutagenesis to study salt tolerance |
Metabolic Disorders and Hyperinsulinism
Dysregulation of GLUD1, the gene encoding NAD-dependent glutamate dehydrogenase, is associated with hyperinsulinism/hyperammonemia syndrome, a metabolic disorder characterized by excessive insulin secretion and elevated ammonia levels. Although direct citations in this article focus on stem cell fate, the enzyme's role in glutamate oxidation and ammonia production provides a mechanistic link to such pathologies. Research using knockout and point mutation models can elucidate how altered GO:0004352 activity contributes to disease.
Neurodegeneration and Brain Ischemia
Glutamate excitotoxicity and oxidative stress are hallmarks of brain ischemia. Oxidative stress in brain ischemia can impair mitochondrial function, including enzymes like glutamate dehydrogenase, potentially exacerbating neuronal damage. The NAD-dependent activity of GDH is critical for maintaining glutamate homeostasis; its dysfunction may contribute to excitotoxic injury. Studying GO:0004352 in neuronal models can reveal protective or detrimental roles.
Cancer Metabolism
Cancer cells often reprogram glutamine and glutamate metabolism to support growth. NAD-dependent glutamate dehydrogenase activity, by producing 2-oxoglutarate for the TCA cycle, can fuel anabolic pathways. Although direct cancer citations are not included here, the enzyme's role in mitochondrial glutamate homeostasis suggests it may be a target for metabolic cancer therapy. Experimental models with GLUD1 knockout or overexpression can test this hypothesis.
From L-glutamate dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLUD1 loss affect muscle stem cell fate? | GLUD1 knockout mouse model and primary muscle stem cells |
| How does L-leucine activate GDH? | Point mutations in allosteric sites followed by enzyme kinetics |
| What is the role of NAD-GDH in cold adaptation? | Heterologous expression of Janthinobacterium lividum GDH in E. coli |
| Can GDH inhibition reduce parasite survival? | Trypanosoma cruzi GDH knockout or knockdown |
| Does oxidative stress modify GDH activity? | Neuronal cells with tagged GLUD1 and oxidative stress induction |
| How do TCA intermediates regulate archaeal GDH? | Halobacterium halobium GDH mutants and metabolite profiling |
How to Study the L-glutamate dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity via NADH production | Kinetic characterization of GDH |
| CRISPR knockout | Loss-of-function phenotype | Stem cell fate and metabolic studies |
| Metabolomics | Glutamate and 2-oxoglutarate levels | Flux analysis in cells and tissues |
| X-ray crystallography | Three-dimensional structure | Active site and allosteric site mapping |
| Site-directed mutagenesis | Specific residue function | Mechanistic studies of catalysis |
| RNA-seq | Transcriptional changes upon GDH perturbation | Pathway analysis in knockout models |
| Western blot | Protein expression levels | Validation of knockout or overexpression |
| Immunofluorescence | Subcellular localization | Mitochondrial targeting of GLUD1 |
Enzymatic Activity Assays
Direct measurement of NAD-dependent glutamate dehydrogenase activity is performed by monitoring NADH production at 340 nm in the presence of L-glutamate and NAD+. This method is used to characterize enzyme kinetics, allosteric regulation, and inhibitor effects.
Genetic Knockout and Knockdown
CRISPR-Cas9 knockout or RNA interference knockdown of GLUD1 or other GDH genes allows researchers to assess loss-of-function phenotypes. In muscle stem cells, GLUD1 knockout revealed its role in cell fate determination. Similar approaches in parasites and bacteria can elucidate essential functions.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics quantifies glutamate, 2-oxoglutarate, and related metabolites to assess flux through GO:0004352. Isotope tracing with 13C-glutamate can measure dehydrogenase activity in living cells.
Structural and Biophysical Methods
X-ray crystallography and cryo-EM provide structural insights into substrate binding and allostery. These methods have been applied to NAD-GDHs from Janthinobacterium lividum and Halobacterium halobium.
How CRISPR Can Be Used to Study GO:0004352 L-glutamate dehydrogenase (NAD+) activity
Knockout
CRISPR-Cas9 knockout of GLUD1 or other NAD-GDH genes creates null alleles to study loss of GO:0004352 activity. This approach has been used to demonstrate that GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels. Knockout models are essential for distinguishing the specific roles of NAD-dependent versus NADP-dependent glutamate dehydrogenases.
Point Mutation
Point mutations can be introduced into the active site or allosteric sites of GDH to dissect catalytic residues and regulatory mechanisms. For example, mutations affecting L-leucine activation can be modeled to understand allosteric control. Such models help validate structural predictions and identify critical amino acids.
Knock-in
Knock-in of tagged or reporter versions of GDH (e.g., GFP or HA tags) allows real-time tracking of enzyme localization and dynamics. Tagged knock-in models are valuable for imaging studies in mitochondria and for immunoprecipitation of protein complexes.
Overexpression
Overexpression of wild-type or mutant GDH can reveal gain-of-function phenotypes, such as altered glutamate flux or redox balance. In cancer metabolism research, overexpression models can test whether increased GO:0004352 activity promotes proliferation or survival.
How EDITGENE Supports L-glutamate dehydrogenase (NAD+) activity Research
Researchers studying L-glutamate dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, stem cell fate, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of GO:0004352 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for L-glutamate dehydrogenase (NAD+) activity research.
Frequently Asked Questions About L-glutamate dehydrogenase (NAD+) activity
What is L-glutamate dehydrogenase (NAD+) activity?
It is a molecular function defined by GO:0004352 that catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate and ammonia, using NAD+ as an electron acceptor.
What genes are involved in L-glutamate dehydrogenase (NAD+) activity?
The primary gene in mammals is GLUD1, encoding the mitochondrial NAD-dependent glutamate dehydrogenase. Other organisms have orthologs such as gdhA in Halobacterium halobium and GDH1 in Janthinobacterium lividum.
What is the reaction catalyzed by GO:0004352?
The reaction is: L-glutamate + NAD+ + H2O = 2-oxoglutarate + NH4+ + NADH + H+.
How is NAD-dependent glutamate dehydrogenase regulated?
It is allosterically activated by L-leucine and modulated by TCA cycle intermediates and amino acids.
What diseases are associated with glutamate dehydrogenase dysfunction?
Dysregulation has been linked to hyperinsulinism/hyperammonemia syndrome, brain ischemia, and cancer metabolism.
What is the difference between NAD-dependent and NADP-dependent glutamate dehydrogenase?
NAD-dependent GDH (GO:0004352) uses NAD+ and typically functions in catabolism, while NADP-dependent GDH uses NADP+ and is often involved in biosynthesis.
How can I study L-glutamate dehydrogenase (NAD+) activity in the lab?
Common methods include NADH absorbance assays, CRISPR knockout, metabolomics, and structural biology.
What cell models are available for GDH research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression models for GLUD1 and related genes.
Is GLUD1 essential for muscle stem cell function?
Yes, studies show that GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels.
Can CRISPR be used to modify GDH genes?
Yes, CRISPR-Cas9 can create knockouts, point mutations, and knock-ins in GDH genes for functional studies.
Conclusion
GO:0004352, L-glutamate dehydrogenase (NAD+) activity, represents a critical metabolic function that links amino acid catabolism to energy production and redox balance. Its regulation by metabolites and its role in stem cell fate and disease make it a compelling target for research. By leveraging CRISPR-based models and advanced analytical methods, scientists can uncover new insights into this enzyme's biology and its therapeutic potential.
References
- 1. Soro-Arnáiz I et al.. 2024. GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels.. Dev Cell 59(21):2850-2865.e8 PMID: 39121856
- 3. Couée I et al.. 1989. Activation of glutamate dehydrogenase by L-leucine.. Biochim Biophys Acta 995(1):97-101 PMID: 2923920
- 4. Kawakami R et al.. 2007. Gene cloning and characterization of the very large NAD-dependent l-glutamate dehydrogenase from the psychrophile Janthinobacterium lividum, isolated from cold soil.. J Bacteriol 189(15):5626-33 PMID: 17526698
- 5. Bonete MJ et al.. 1996. NAD-glutamate dehydrogenase from Halobacterium halobium: inhibition and activation by TCA intermediates and amino acids.. Biochim Biophys Acta 1289(1):14-24 PMID: 8605224
- 6. Moyano E et al.. 1992. Purification and properties of three NAD(P)+ isozymes of L-glutamate dehydrogenase of Chlamydomonas reinhardtii.. Biochim Biophys Acta 1119(1):63-8 PMID: 1540636
- 7. Carneiro VT et al.. 1983. Regulatory studies of L-glutamate dehydrogenase from Trypanosoma cruzi epimastigotes.. Comp Biochem Physiol B 75(1):61-4 PMID: 6133680
- 8. Love S. 1999. Oxidative stress in brain ischemia.. Brain Pathol 9(1):119-31 PMID: 9989455
